BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 31398337)

  • 1. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.
    Riquelme E; Zhang Y; Zhang L; Montiel M; Zoltan M; Dong W; Quesada P; Sahin I; Chandra V; San Lucas A; Scheet P; Xu H; Hanash SM; Feng L; Burks JK; Do KA; Peterson CB; Nejman D; Tzeng CD; Kim MP; Sears CL; Ajami N; Petrosino J; Wood LD; Maitra A; Straussman R; Katz M; White JR; Jenq R; Wargo J; McAllister F
    Cell; 2019 Aug; 178(4):795-806.e12. PubMed ID: 31398337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot study.
    Chu CS; Yang CY; Yeh CC; Lin RT; Chen CC; Bai LY; Hung MC; Lin CC; Wu CY; Lin JT
    Sci Rep; 2022 Jan; 12(1):107. PubMed ID: 34997106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the pancreatic cancer microbiome in Mainland China: Impact of Exiguobacterium/Bacillus ratio on tumor progression and prognostic significance.
    Zhang Z; Wang T; Xu M; Zhang Z; Wang H; Xue J; Wang W
    Pharmacol Res; 2024 Jun; 204():107197. PubMed ID: 38692467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.
    Thomas RM; Gharaibeh RZ; Gauthier J; Beveridge M; Pope JL; Guijarro MV; Yu Q; He Z; Ohland C; Newsome R; Trevino J; Hughes SJ; Reinhard M; Winglee K; Fodor AA; Zajac-Kaye M; Jobin C
    Carcinogenesis; 2018 Jul; 39(8):1068-1078. PubMed ID: 29846515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor Microbiome Analysis Identifies Positive Association Between
    Huang Y; Zhu N; Zheng X; Liu Y; Lu H; Yin X; Hao H; Tan Y; Wang D; Hu H; Liang Y; Li X; Hu Z; Yin Y
    Front Immunol; 2022; 13():785422. PubMed ID: 35145519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
    Mendez R; Kesh K; Arora N; Di Martino L; McAllister F; Merchant N; Banerjee S; Banerjee S
    Carcinogenesis; 2020 Jul; 41(5):561-570. PubMed ID: 31369062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention.
    Halpin AL; de Man TJ; Kraft CS; Perry KA; Chan AW; Lieu S; Mikell J; Limbago BM; McDonald LC
    Am J Infect Control; 2016 Jul; 44(7):830-6. PubMed ID: 26905790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metagenomic study of the gut microbiome in Behcet's disease.
    Ye Z; Zhang N; Wu C; Zhang X; Wang Q; Huang X; Du L; Cao Q; Tang J; Zhou C; Hou S; He Y; Xu Q; Xiong X; Kijlstra A; Qin N; Yang P
    Microbiome; 2018 Aug; 6(1):135. PubMed ID: 30077182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics.
    Qian J; Zhang X; Wei B; Tang Z; Zhang B
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188943. PubMed ID: 37355177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiome signatures of pancreatic cancer patients.
    Half E; Keren N; Reshef L; Dorfman T; Lachter I; Kluger Y; Reshef N; Knobler H; Maor Y; Stein A; Konikoff FM; Gophna U
    Sci Rep; 2019 Nov; 9(1):16801. PubMed ID: 31727922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma.
    Pfisterer N; Ammer-Herrmenau C; Antweiler K; Küffer S; Ellenrieder V; Neesse A
    Pancreatology; 2023 Sep; 23(6):663-673. PubMed ID: 37541802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review).
    Huang X; Li M; Hou S; Tian B
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34738624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study.
    Olson SH; Satagopan J; Xu Y; Ling L; Leong S; Orlow I; Saldia A; Li P; Nunes P; Madonia V; Allen PJ; O'Reilly E; Pamer E; Kurtz RC
    Cancer Causes Control; 2017 Sep; 28(9):959-969. PubMed ID: 28762074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbiota and microbiome in pancreatic cancer: more influential than expected.
    Wei MY; Shi S; Liang C; Meng QC; Hua J; Zhang YY; Liu J; Zhang B; Xu J; Yu XJ
    Mol Cancer; 2019 May; 18(1):97. PubMed ID: 31109338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 17. Pancreatic cancer survival analysis defines a signature that predicts outcome.
    Raman P; Maddipati R; Lim KH; Tozeren A
    PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal investigation of the swine gut microbiome from birth to market reveals stage and growth performance associated bacteria.
    Wang X; Tsai T; Deng F; Wei X; Chai J; Knapp J; Apple J; Maxwell CV; Lee JA; Li Y; Zhao J
    Microbiome; 2019 Jul; 7(1):109. PubMed ID: 31362781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.
    Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R
    Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.